post featured image

Olivia Dean

9 November 2021

Director of IMPACT’s TRIALS group, Dr Olivia Dean leads a novel therapies program, with experience in developing and coordinating several successful multi-centre national and international randomised controlled trials in mental health.  In addition to her role directing current clinical trials, Olivia has broad research interests including anti-inflammatory treatments for depression, oxidative biology and autism, mitochondrial dysfunction in bipolar disorder, and molecular markers of psychiatric illness.

Research interests

Affective and anxiety disorders